Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials

Authors: Rui Zhang, Qin-chuan Hou, Bing-hong Li, Ling Deng, Yu-mei Yang, Ting-xin Li, Xiao-qin Yao, Liang-liang Yang, Xi-long Lin, Yi-qian Liao, Lin Wang, Yu-ping Liu, Jing Tan, Zheng-wei Wan, Ping Shuai

Source: Frontiers in Endocrinology, Vol 14 (2023)

Subject Terms: semaglutide, overweight, obese, meta-analysis, subgroup, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fendo.2023.1132004/full; https://doaj.org/toc/1664-2392

Access URL: https://doaj.org/article/fb36e515c5c7463ba0f56f6a450e94c7